capital riesgo biotecnología

capital riesgo biotecnología

Te acompañamos en cada paso
Array ( [0] => WP_Term Object ( [term_id] => 238 [name] => biotecnología [slug] => biotecnologia [term_group] => 0 [term_taxonomy_id] => 238 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 22 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 629 [name] => capital riesgo biotecnología [slug] => capital-riesgo-biotecnologia [term_group] => 0 [term_taxonomy_id] => 629 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 630 [name] => m&a capital riesgo [slug] => ma-capital-riesgo [term_group] => 0 [term_taxonomy_id] => 630 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) )
Las biotecnológicas en contra del cáncer reciben financiación: Immunostep y Dp Pharma
En el último mes hemos conocido dos empresas españolas que centran su actividad en la lucha contra el cáncer, Immunos [...]
seguir leyendo >>
closechevron-downcrossmenuchevron-down